Recommendations for Improving the Quality of Rare Disease Registries
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Rare diseases (RD) patient registries are powerful instruments that help develop clinical research, facilitate the planning of appropriate clinical trials, improve patient care, and support healthcare management. They constitute a key information system that supports the activities of European Reference Networks (ERNs) on rare diseases. A rapid proliferation of RD registries has occurred during the last years and there is a need to develop guidance for the minimum requirements, recommendations and standards necessary to maintain a high-quality registry. In response to these heterogeneities, in the framework of RD-Connect, a European platform connecting databases, registries, biobanks and clinical bioinformatics for rare disease research, we report on a list of recommendations, developed by a group of experts, including members of patient organizations, to be used as a framework for improving the quality of RD registries. This list includes aspects of governance, Findable, Accessible, Interoperable and Reusable (FAIR) data and information, infrastructure, documentation, training, and quality audit. The list is intended to be used by established as well as new RD registries. Further work includes the development of a toolkit to enable continuous assessment and improvement of their organizational and data quality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The FAIR Guiding Principles for scientific data management and stewardship
Wilkinson, M. D., Dumontier, M., Aalbersberg, I. J., Appleton, G., Axton, M., Baak, A., Blomberg, N., Boiten, J.-W., da Silva Santos, L. B., Bourne, P. E., et al. (2016) · Scientific Data · doi:10.1038/sdata.2016.18 · Cited by 18,423 · cited 1×
“To mitigate this problem, we recommend ‘data stewardship’ at the source and the application of the FAIR Guiding Principles for scientific data management and stewardship [54], which have recently been accepted as an IRDiRC recognized resource.”
MethodSelf-citationStudy Design, Precision, and Validity in Observational Studies
Carlson, M. D. A., & Morrison, R. S. (2009) · Journal of Palliative Medicine · doi:10.1089/jpm.2008.9690 · Cited by 517 · cited 1×
“Secondary data sources may also cover a large geographic area and thus provide the ability to assess national trends; a disadvantage is that the data may not include all variables of interest [28].”
BackgroundRegistry-based randomized clinical trials—a new clinical trial paradigm
James, S., Rao, S. V., & Granger, C. B. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.33 · Cited by 331 · cited 1×
“Recently, a new registry category, called registry-based randomized controlled trials, has been included [14].”
BackgroundLi, G., Sajobi, T. T., Menon, B. K., Korngut, L., Lowerison, M., James, M., Wilton, S. B., Williamson, T., Gill, S., Drogos, L. L., et al. (2016) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2016.08.003 · Cited by 247 · cited 1×
“The advantages of registry based randomized controlled trials include low cost, enhanced generalizability of findings, rapid consecutive enrolment, and the potential completeness of follow-up for the reference population [15].”
BackgroundPatient participation as dialogue: setting research agendas
Abma, T. A., & Broerse, J. E. W. (2010) · Health Expectations · doi:10.1111/j.1369-7625.2009.00549.x · Cited by 245 · cited 1×
“In the context of the registry, the Dialogue Model appeared feasible to structure the process of collaboration between stakeholders and patient organizations [17].”
BackgroundInternational Charter of principles for sharing bio-specimens and data
Mascalzoni, D., Dove, E. S., Rubinstein, Y., Dawkins, H. J. S., Kole, A., McCormack, P., Woods, S., Riess, O., Schaefer, F., Lochmüller, H., et al. (2015) · European Journal of Human Genetics · doi:10.1038/ejhg.2014.197 · Cited by 156 · cited 1×
“Consequently, helping data providers identify relevant ethical and legal requirements and how these can be addressed is an essential, but frequently neglected, step when removing possible hurdles to data and sample sharing in the life sciences [19,20].”
BackgroundSelf-citationChoquet, R., Maaroufi, M., de Carrara, A., Messiaen, C., Luigi, E., & Landais, P. (2014) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2014-002794 · Cited by 111 · cited 1×
“- The French minimum data set for rare diseases (F-MDS-RD) is a minimum set of DEs agreed for mandatory collection and reporting at the national level [45].”
BackgroundSelf-citationCommonly Used Data-collection Approaches in Clinical Research
Saczynski, J. S., McManus, D. D., & Goldberg, R. J. (2013) · The American Journal of Medicine · doi:10.1016/j.amjmed.2013.04.016 · Cited by 103 · cited 1×
“It is often useful and time well spent to identify data elements that are essential or absolutely necessary and those that are “optional” or “desirable”, but may not be considered central to the key study hypothesis [30].”
BackgroundEvaluation and implementation of public health registries.
Solomon, D., HENRY, R. C., Hogan, J. G., Amburg, H. V., & Taylor, J. (1991) · Europe PMC (PubMed Central) · Cited by 100
The European Bioinformatics Institute (EMBL-EBI) in 2021
Cantelli, G., Bateman, A., Brooksbank, C., Petrov, A. I., Malik-Sheriff, R. S., Ide-Smith, M., Hermjakob, H., Flicek, P., Apweiler, R., Birney, E., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkab1127 · Cited by 96
Data Quality in Rare Diseases Registries
Kodra, Y., de la Paz, M. P., Coi, A., Santoro, M. C., Bianchi, F., Ahmed, S. F., Rubinstein, Y., Weinbach, J., & Taruscio, D. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-67144-4_8 · Cited by 90 · cited 2×
“The quality of data is defined by attributes such as completeness, accuracy, timeless, usefulness, interoperability, accessibility, and data security [13].”
BackgroundSelf-citationGainotti, S., Turner, C., Woods, S., Kole, A., McCormack, P., Lochmüller, H., Rieß, O., Straub, V. W., de la Paz, M. P., Taruscio, D., et al. (2016) · European Journal of Human Genetics · doi:10.1038/ejhg.2016.2 · Cited by 70 · cited 1×
“Consent is often required for publications and for international projects [22], and there is a need for improving the informed consent process in international collaborative rare disease research—effective consent for effective research.”
BackgroundSelf-citationThe Common Data Elements for Cancer Research: Remarks on Functions and Structure
Brandt, C., & Nadkarni, P. (2006) · Methods of Information in Medicine · doi:10.1055/s-0038-1634121 · Cited by 61 · cited 1×
“- National Cancer Institute for Bioinformatics (NCICB) has developed the Common Data Elements (CDEs) for the cancer field [32].”
Backgroundde Groot, S., van der Linden, N., Franken, M. G., Blommestein, H. M., Leeneman, B., van Rooijen, E., van der Hoeven, J. J. M., Wouters, M. W. J. M., Westgeest, H. M., & Groot, C. A. U. (2016) · Value in Health · doi:10.1016/j.jval.2016.02.007 · Cited by 45 · cited 1×
“Multi-sponsor registries decrease the financial burden on each party, secure wider support, and limit financial risks when funding from one source fails [27].”
BackgroundRare Disease Registries Classification and Characterization: A Data Mining Approach
Santoro, M. C., Coi, A., Paola, M. L. D., Bianucci, A. M., Gainotti, S., Mollo, E., Taruscio, D., Vittozzi, L., & Bianchi, F. (2015) · Public Health Genomics · doi:10.1159/000369993 · Cited by 37 · cited 1×
“, aspects that belong to more than one registry type) [11,12].”
BackgroundSelf-citationSariyar, M., Schlünder, I., Smee, C., & Suhr, S. B. (2015) · Biopreservation and Biobanking · doi:10.1089/bio.2015.0014 · Cited by 37 · cited 1×
“Consequently, helping data providers identify relevant ethical and legal requirements and how these can be addressed is an essential, but frequently neglected, step when removing possible hurdles to data and sample sharing in the life sciences [19,20].”
BackgroundRegisters needed for new interventional procedures
Lyratzopoulos, G., Patrick, H. E., & Campbell, B. K. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60742-4 · Cited by 33 · cited 1×
“Private-public partnerships have shown increasing interest in registries, to improve safety monitoring, compare effectiveness goals, and streamline the costs of drug or disposal development processes [26].”
BackgroundThe Quality of Rare Disease Registries: Evaluation and Characterization
Coi, A., Santoro, M. C., Villaverde‐Hueso, A., Paola, M. L. D., Gainotti, S., Taruscio, D., de la Paz, M. P., & Bianchi, F. (2016) · Public Health Genomics · doi:10.1159/000444476 · Cited by 27 · cited 2×
“High-quality RD registries have policies in place to ensure long-term sustainability and low quality registries are more likely to have been set up with few or no funds [25].”
BackgroundSelf-citationErratum: International Charter of principles for sharing bio-specimens and data
Mascalzoni, D., Dove, E. S., Rubinstein, Y., Dawkins, H. J. S., Kole, A., McCormack, P., Woods, S., Rieß, O., Schaefer, F. S., Lochmüller, H., et al. (2016) · European Journal of Human Genetics · doi:10.1038/ejhg.2015.237 · Cited by 14
Self-citationNeurological Registry Best Practice Guidelines - Complete Document
(2013) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100017091 · Cited by 6
Cited by
Adachi, T., El-Hattab, A. W., Jain, R., Nogales Crespo, K. A., Quirland Lazo, C. I., Scarpa, M., Summar, M., & Wattanasirichaigoon, D. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20064732 · Cited by 168
Opportunities and Challenges for Molecular Understanding of Ciliopathies–The 100,000 Genomes Project
Wheway, G., Genomics England Research Consortium, & Mitchison, H. M. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00127 · Cited by 99
Data Quality in Health Research: A Systematic Literature Review
Bernardi, F. A., Alves, D., Crepaldi, N. Y., Yamada, D. B., Lima, V. C., & Lopes Rijo, R. P. C. (2022) · doi:10.1101/2022.05.31.22275804 · Cited by 4
Metadata
- Authors
- Kodra, Y., Weinbach, J., Posada-de-la-Paz, M., Coi, A., Lemonnier, S. L., Van Enckevort, D., Roos, M., Jacobsen, A., Cornet, R., Ahmed, S. F., Bros-Facer, V., Popa, V., Van Meel, M., Renault, D., Von Gizycki, R., Santoro, M., Landais, P., Torreri, P., Carta, C., Mascalzoni, D., Gainotti, S., Lopez, E., Ambrosini, A., Müller, H., Reis, R., Bianchi, F., Rubinstein, Y. R., Lochmüller, H., & Taruscio, D.
- Venue
- International Journal of Environmental Research and Public Health
- Publisher
- MDPI AG
- Published
- 2018-08-03
- Volume
- 15
- Issue
- 8
- Pages
- 1644
- ISSN
- 1660-4601 (ISSN-L)
- OpenAlex
- W2886173545
- Cited by
- 189
- References
- 20
- FWCI
- 27.32
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.